T1	Treatment 19 38	tobramycin aerosols
T2	Treatment 194 204	tobramycin
T3	Treatment 499 637	intravenous betalactam and tobramycin were randomly allocated to receive aerosolized tobramycin (6 mg/kg/day, n = 21) or placebo (n = 17).
T4	Treatment 638 715	The aerosol was administered via a pneumatic nebulizer once a day for 5 days.
